| Berj Dermendjian, DO | |
|
10624 S Eastern Ave # A-955, Henderson, NV 89052-2982 | |
| (702) 800-5393 | |
| (702) 407-7016 |
| Full Name | Berj Dermendjian |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 10624 S Eastern Ave # A-955, Henderson, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225488851 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | DO2469 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sherman Oaks Hospital | Sherman oaks, CA | Hospital |
| Huntington Memorial Hospital | Pasadena, CA | Hospital |
| Encino Hospital Medical Center | Encino, CA | Hospital |
| Casitas Care Center | Granada hills, CA | Nursing home |
| The Care Center On Hazeltine, Llc | Van nuys, CA | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Center For Family Health And Education Inc | 3678714201 | 13 |
| Epic Medical Group,inc | 4385883958 | 41 |
| Southern California Hospitalist Network Medical Group Inc | 8921990110 | 74 |
News Archive
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects.
Scientists from RIKEN in Japan have discovered that acrolein—a toxic substance produced in cells during times of oxidative stress—in fact may play a role in preventing the process of fibrillation, an abnormal clumping of peptides that has been associated with Alzheimer's disease and other neural diseases.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced that on July 26, 2010 it received a letter from the NYSE Amex LLC, stating that PharmAthene is not in compliance with the continued listing standards specified in Sections 1003(a)(i), (ii) and (iii) of the NYSE Amex Company Guide, because it has stockholders' equity of less than $2.0 million, $4.0 million and $6.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years, three of its four most recent fiscal years and its five most recent fiscal years, respectively.
A new study found that an extremely infectious pneumonia-like disease in humans slips through the immune system's usual defense mechanisms.
In an interview with the Des Moines Register, President Barack Obama said he'll begin sequester talks right after the election, offering a package of spending cuts and tax increases as well as plans to reduce the costs of health care programs. Meanwhile, The Wall Street Journal reports that leaders of some of the nation's largest companies plan to pressure Congress to make a deal that would include tax increases as well as spending cuts.
› Verified 2 days ago
| Entity Name | Southern California Hospitalist Network Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790880458 PECOS PAC ID: 8921990110 Enrollment ID: O20040324001749 |
News Archive
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects.
Scientists from RIKEN in Japan have discovered that acrolein—a toxic substance produced in cells during times of oxidative stress—in fact may play a role in preventing the process of fibrillation, an abnormal clumping of peptides that has been associated with Alzheimer's disease and other neural diseases.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced that on July 26, 2010 it received a letter from the NYSE Amex LLC, stating that PharmAthene is not in compliance with the continued listing standards specified in Sections 1003(a)(i), (ii) and (iii) of the NYSE Amex Company Guide, because it has stockholders' equity of less than $2.0 million, $4.0 million and $6.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years, three of its four most recent fiscal years and its five most recent fiscal years, respectively.
A new study found that an extremely infectious pneumonia-like disease in humans slips through the immune system's usual defense mechanisms.
In an interview with the Des Moines Register, President Barack Obama said he'll begin sequester talks right after the election, offering a package of spending cuts and tax increases as well as plans to reduce the costs of health care programs. Meanwhile, The Wall Street Journal reports that leaders of some of the nation's largest companies plan to pressure Congress to make a deal that would include tax increases as well as spending cuts.
› Verified 2 days ago
| Entity Name | Epic Medical Group,inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295178689 PECOS PAC ID: 4385883958 Enrollment ID: O20130612000470 |
News Archive
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects.
Scientists from RIKEN in Japan have discovered that acrolein—a toxic substance produced in cells during times of oxidative stress—in fact may play a role in preventing the process of fibrillation, an abnormal clumping of peptides that has been associated with Alzheimer's disease and other neural diseases.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced that on July 26, 2010 it received a letter from the NYSE Amex LLC, stating that PharmAthene is not in compliance with the continued listing standards specified in Sections 1003(a)(i), (ii) and (iii) of the NYSE Amex Company Guide, because it has stockholders' equity of less than $2.0 million, $4.0 million and $6.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years, three of its four most recent fiscal years and its five most recent fiscal years, respectively.
A new study found that an extremely infectious pneumonia-like disease in humans slips through the immune system's usual defense mechanisms.
In an interview with the Des Moines Register, President Barack Obama said he'll begin sequester talks right after the election, offering a package of spending cuts and tax increases as well as plans to reduce the costs of health care programs. Meanwhile, The Wall Street Journal reports that leaders of some of the nation's largest companies plan to pressure Congress to make a deal that would include tax increases as well as spending cuts.
› Verified 2 days ago
| Entity Name | Center For Family Health And Education Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871853481 PECOS PAC ID: 3678714201 Enrollment ID: O20130724000805 |
News Archive
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects.
Scientists from RIKEN in Japan have discovered that acrolein—a toxic substance produced in cells during times of oxidative stress—in fact may play a role in preventing the process of fibrillation, an abnormal clumping of peptides that has been associated with Alzheimer's disease and other neural diseases.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced that on July 26, 2010 it received a letter from the NYSE Amex LLC, stating that PharmAthene is not in compliance with the continued listing standards specified in Sections 1003(a)(i), (ii) and (iii) of the NYSE Amex Company Guide, because it has stockholders' equity of less than $2.0 million, $4.0 million and $6.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years, three of its four most recent fiscal years and its five most recent fiscal years, respectively.
A new study found that an extremely infectious pneumonia-like disease in humans slips through the immune system's usual defense mechanisms.
In an interview with the Des Moines Register, President Barack Obama said he'll begin sequester talks right after the election, offering a package of spending cuts and tax increases as well as plans to reduce the costs of health care programs. Meanwhile, The Wall Street Journal reports that leaders of some of the nation's largest companies plan to pressure Congress to make a deal that would include tax increases as well as spending cuts.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Berj Dermendjian, DO 10624 S Eastern Ave # A-955, Henderson, NV 89052-2982 Ph: (702) 800-5393 | Berj Dermendjian, DO 10624 S Eastern Ave # A-955, Henderson, NV 89052-2982 Ph: (702) 800-5393 |
News Archive
Researchers at The University of Texas MD Anderson Cancer Center have developed a novel targeted therapy, called POMHEX, which blocks critical metabolic pathways in cancer cells with specific genetic defects.
Scientists from RIKEN in Japan have discovered that acrolein—a toxic substance produced in cells during times of oxidative stress—in fact may play a role in preventing the process of fibrillation, an abnormal clumping of peptides that has been associated with Alzheimer's disease and other neural diseases.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced that on July 26, 2010 it received a letter from the NYSE Amex LLC, stating that PharmAthene is not in compliance with the continued listing standards specified in Sections 1003(a)(i), (ii) and (iii) of the NYSE Amex Company Guide, because it has stockholders' equity of less than $2.0 million, $4.0 million and $6.0 million and losses from continuing operations and/or net losses in two of its three most recent fiscal years, three of its four most recent fiscal years and its five most recent fiscal years, respectively.
A new study found that an extremely infectious pneumonia-like disease in humans slips through the immune system's usual defense mechanisms.
In an interview with the Des Moines Register, President Barack Obama said he'll begin sequester talks right after the election, offering a package of spending cuts and tax increases as well as plans to reduce the costs of health care programs. Meanwhile, The Wall Street Journal reports that leaders of some of the nation's largest companies plan to pressure Congress to make a deal that would include tax increases as well as spending cuts.
› Verified 2 days ago
James B Gabroy, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1535 West Warm Spring Road, Suite 135, Henderson, NV 89014 Phone: 702-450-3385 Fax: 702-898-1699 | |
Dr. Poupak Ziaei, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2641 W Horizon Ridge Pkwy Ste 100, Henderson, NV 89052 Phone: 702-616-0091 Fax: 702-616-2329 | |
Dr. Jeannette Nee, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2865 Siena Heights Dr, Suite 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Wen Liang, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2621 W Horizon Ridge Pkwy, Suite 150, Henderson, NV 89052 Phone: 702-837-6368 Fax: 702-837-0685 | |
Randy James Ip, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 | |
Linda Lou Johnson, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 W Sunset Rd, Henderson, NV 89014 Phone: 725-269-7001 Fax: 725-269-7003 | |
Dr. Daejoon Anh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2865 Siena Heights Dr Ste 331, Henderson, NV 89052 Phone: 702-407-0110 Fax: 702-407-0133 |